Cross-Sectional Survey on the Use of Tobacco Products - Germany

Tobacco Use Clinical Trial

Official title: Cross-Sectional Survey on the Use of Tobacco Products in the General Population and in Users of IQOS in Germany (2018-2020)

Status Terminated

Clinical Trial Summary

The main purpose of the research study is to estimate the prevalence of tobacco product use and describe the tobacco use patterns in adults in Germany.

Clinical Trial Description

The aim of the survey is to describe the current and past patterns of use of tobacco products in the general adult population of Germany and in adult IQOS users registered in the IQOS user database of Philip Morris GmbH (Germany IQOS User Database), and explore their association with key independent variables. More specifically, the objectives are:

1. Estimate the prevalence of current tobacco use status in the study population.

2. Describe the past tobacco use status (cigarette, IQOS and other innovative products, including e-cigarettes) in the study population (i.e. never-use, initiation, product use transition, cessation, re-initiation, and relapse).

3. Explore the association between self-reported health status and use of tobacco products in the study population.

4. Explore the association between patterns of use (including misuse) with motivation to use, perceived quality attributes of IQOS (e.g. risk and self-reported changes since switching to the product, in a number of relevant domains where IQOS may have potential benefits), and consumer's satisfaction in the population of IQOS users in Germany registered in the Germany IQOS User Database. ;

Related Conditions & MeSH terms

• Tobacco Use

• NCT number: NCT03527017
• Study type: Observational
• Source: Philip Morris Products S.A.
• Status: Terminated
• Start date: March 12, 2018
• Completion date: February 24, 2020